IntrinsicIntrinsic

Other Events ·

Jaguar Health, Inc. reconvened its 2026 Annual Meeting of Stockholders on June 8, 2026, and approved five proposals…

JAGXJaguar Health, Inc.

Jaguar Health, Inc. reconvened its 2026 Annual Meeting of Stockholders on June 8, 2026, and approved five proposals, including the election of a Class II director and the ratification of RBSM LLP as independent auditor. Notably, stockholders' approval was the result of 7,169,152 shares represented, out of a total of 14,044,277 shares outstanding.

More from Jaguar Health, Inc.

Explore JAGX